CBP-1008
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CBP-1008, covering 2024-08-28 to 2024-08-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CBP-1008 in Patients With Advanced Solid Tumor [Phase 1]